Home > Boards > US Listed > Medical - Drugs > Horizon Pharma, Inc. (HZNP)

HZNP Chugging back up this morning.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
MiamiGent Member Profile
Member Level 
Followed By 210
Posts 31,909
Boards Moderated 4
Alias Born 08/16/08
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/15/2019 4:20:48 PM
FORTUNE and Great Place to Work® Name Horizon Therapeutics plc to Best Workplaces for Parents List Business Wire - 11/14/2019 9:30:00 AM
Horizon Therapeutics plc to Participate in Upcoming Investor Conferences Business Wire - 11/13/2019 4:15:00 PM
Data from Uncontrolled Gout Case Series Supports Immunomodulation with KRYSTEXXA® (pegloticase injection) Strategy to Optimi... Business Wire - 11/11/2019 8:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:09:01 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:08:31 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:07:45 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:07:10 PM
The Chicago Tribune Names Horizon Therapeutics plc a 2019 Top Workplace Business Wire - 11/8/2019 9:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/7/2019 4:40:06 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 7:18:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 7:08:35 AM
Horizon Therapeutics plc Reports Strong Third-Quarter 2019 Results Business Wire - 11/6/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 5:04:57 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/5/2019 5:02:43 PM
Horizon Therapeutics plc Brings Gout-Kidney Link into Focus during American Society of Nephrology (ASN) Kidney Week 2019 Business Wire - 11/5/2019 8:00:00 AM
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presented Durin... Business Wire - 11/4/2019 8:30:00 AM
New Evidence on the Burden of Gout to be Featured in Data Presentations at Upcoming ACR Annual Meeting Business Wire - 11/4/2019 8:00:00 AM
Integrated Clinical Trial Analyses Further Substantiate that Teprotumumab Significantly Improves Debilitating Effects of Thyr... Business Wire - 10/31/2019 10:00:00 AM
Horizon Therapeutics plc Named One of the Most Innovative Companies by Crain’s Chicago Business Business Wire - 10/24/2019 11:15:00 AM
New Combined Data from the Phase 2 & Phase 3 Teprotumumab Clinical Trials to be Presented during the American Thyroid Associa... Business Wire - 10/24/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/17/2019 4:43:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/17/2019 4:42:08 PM
FORTUNE & Great Place to Work® Name Horizon Therapeutics plc to Best Small & Medium Workplaces List for Fourth Consecutive Y... Business Wire - 10/17/2019 9:00:00 AM
Horizon Therapeutics plc Initiates PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) to Improve Management of Unco... Business Wire - 10/17/2019 8:00:00 AM
MiamiGent Member Level  Wednesday, 04/13/16 10:46:19 AM
Re: None
Post # of 678 
HZNP Chugging back up this morning.
Ridiculous drop yesterday, imo
Co reiterated guidance
Trade not appreciating numbers will almost always be higher in back end for juggernauts.
Easy peasy, me thinks

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist